Innovation in medicine is often driven by advances in chemistry, particularly in the development of targeted therapeutic agents. For diseases like osteoporosis, understanding the precise chemical interactions at the molecular level is key. 2-Cyanopyrimidine (CAS 14080-23-0) exemplifies this, serving as a potent Cathepsin K inhibitor and a critical compound in the chemical synthesis pathways for new osteoporosis treatments.

The chemical structure of 2-Cyanopyrimidine, a pyrimidine ring with a nitrile substituent, endows it with specific properties that allow it to interact effectively with Cathepsin K. This enzyme, a cysteine protease implicated in bone degradation, is a prime target for therapeutic intervention in osteoporosis. By inhibiting Cathepsin K, the excessive breakdown of bone tissue can be mitigated, potentially leading to improved bone density and reduced fracture risk. The purity of 2-Cyanopyrimidine used in these studies is paramount; typically supplied at >99% purity, it ensures that the observed effects are attributable to the compound itself and not to impurities.

The synthesis of 2-Cyanopyrimidine involves precise chemical reactions, and its availability as a high-quality intermediate is crucial for researchers and pharmaceutical manufacturers. When considering purchasing this compound, factors such as its solubility, stability, and precise molecular weight (105.1 g/mol) are important for formulation and experimental design. Leading chemical suppliers and manufacturers, particularly those based in China, offer this compound with detailed specifications, including CAS number and chemical properties, facilitating its integration into research and development pipelines.

Our company is dedicated to providing researchers and developers with access to essential chemical compounds like 2-Cyanopyrimidine. We understand that robust chemical innovation requires reliable sourcing. By offering this Cathepsin K inhibitor at competitive prices and with a commitment to quality, we aim to support the ongoing development of more effective treatments for osteoporosis. If your research involves targeting Cathepsin K or requires a high-purity pyrimidine derivative, we encourage you to inquire about our supply of 2-Cyanopyrimidine and how we can meet your needs as a trusted manufacturer and supplier.